{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:49:58Z","timestamp":1761155398939},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2008,4,16]],"date-time":"2008-04-16T00:00:00Z","timestamp":1208304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,5,6]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Patients may be referred to the immunology clinic for investigation of recurrent superficial abscess formation. In the majority of adult patients this clinical presentation does not equate with an underlying primary immune deficiency. Nevertheless, recurrent mucocutaneous abscesses can be associated with significant morbidity and long-term complications, including scarring and fistula formation, and may be associated with underlying immune-mediated disease. This review sets out an approach to the patient with recurrent superficial abscesses, focusing on the differential diagnoses, investigation and management of both the common causes and those associated with specific immune deficiency.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2008.03640.x","type":"journal-article","created":{"date-parts":[[2010,7,26]],"date-time":"2010-07-26T21:41:57Z","timestamp":1280180517000},"page":"397-405","source":"Crossref","is-referenced-by-count":28,"title":["Clinical Immunology Review Series: An approach to the patient with recurrent superficial abscesses"],"prefix":"10.1093","volume":"152","author":[{"given":"S L","family":"Johnston","sequence":"first","affiliation":[{"name":"North Bristol NHS Trust, Department of Immunology and Immunogenetics, Southmead Hospital, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2008,4,16]]},"reference":[{"key":"2022010405180981400_b1","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2249.2008.03641.x","article-title":"An approach to the patient with recurrent infections in childhood","author":"Slatter","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"2022010405180981400_b2","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJM199808203390806","article-title":"Staphylococcus aureus infections","volume":"339","author":"Lowy","year":"1998","journal-title":"N Engl J Med"},{"key":"2022010405180981400_b3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1365-2249.2005.02963.x","article-title":"Cellular inflammatory response to persistent localized Staphylococcus aureus infection: phenotypical and functional characterization of polymorphonuclear neutrophils (PMN)","volume":"143","author":"Wagner","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"2022010405180981400_b4","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1086\/517503","article-title":"Successful termination of a furunculosis outbreak due to lukS-lukF-positive, methicillin-susceptible Staphylococcus aureus in a German village by stringent decolonization, 2002\u20132005","volume":"44","author":"Wiese-Posselt","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2022010405180981400_b5","volume-title":"Immunodeficiency: report of a WHO scientific group","author":"World Health Organization (WHO)","year":"1978"},{"key":"2022010405180981400_b6","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1056\/NEJM199912163412507","article-title":"Infections in patients with diabetes mellitus","volume":"341","author":"Joshi","year":"1999","journal-title":"N Engl J Med"},{"key":"2022010405180981400_b7","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1464-5491.1994.tb00250.x","article-title":"Infections and diabetes: mechanisms and prospects for prevention","volume":"11","author":"Pozzilli","year":"1994","journal-title":"Diabet Med"},{"key":"2022010405180981400_b8","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"The Diabetes Control and Complications Trial Research Group","year":"1993","journal-title":"N Engl J Med"},{"key":"2022010405180981400_b9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1396-0296.2004.04007.x","article-title":"Hidradenitis suppurativa: a review","volume":"17","author":"Wiseman","year":"2004","journal-title":"Dermatol Ther"},{"key":"2022010405180981400_b10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2133.2006.07556.x","article-title":"Altered innate and adaptive immune responses in patients with hidradenitis suppurativa","volume":"156","author":"Giamarellos-Bourboulis","year":"2007","journal-title":"Br J Dermatol"},{"key":"2022010405180981400_b11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00054725-200111000-00008","article-title":"Hidradenitis suppurativa and Crohn's disease: response to treatment with infliximab","volume":"7","author":"Mart\u00ednez","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"2022010405180981400_b12","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/j.1365-2133.2003.05663.x","article-title":"Infliximab for hidradenitis suppurativa","volume":"149","author":"Sullivan","year":"2003","journal-title":"Br J Dermatol"},{"key":"2022010405180981400_b13","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1365-2133.2005.07067.x","article-title":"Etanercept: effective in the management of hidradenitis suppurativa","volume":"154","author":"Cusack","year":"2006","journal-title":"Br J Dermatol"},{"key":"2022010405180981400_b14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1479-666X(05)80006-X","article-title":"Experience with different treatment modules in hidradenitis suppurativa: a study of 106 cases","volume":"3","author":"Mandal","year":"2005","journal-title":"Surgeon"},{"key":"2022010405180981400_b15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/00004836-200607000-00003","article-title":"Extraintestinal manifestations of inflammatory bowel disease","volume":"40","author":"Kethu","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"2022010405180981400_b16","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.suc.2007.03.003","article-title":"Extra-intestinal manifestations of Crohn's disease","volume":"87","author":"Ephgrave","year":"2007","journal-title":"Surg Clin N Am"},{"key":"2022010405180981400_b17","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1056\/NEJM199905063401804","article-title":"Infliximab for the treatment of fistulas in patients with Crohn's disease","volume":"340","author":"Present","year":"1999","journal-title":"N Engl J Med"},{"key":"2022010405180981400_b18","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJMoa030815","article-title":"Infliximab maintenance therapy for fistulizing Crohn's disease","volume":"350","author":"Sands","year":"2004","journal-title":"N Engl J Med"},{"key":"2022010405180981400_b19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2249.1999.00109.x","article-title":"Report of an IUIS Scientific Committee. Primary immunodeficiency diseases","volume":"118","author":"IUIS Scientific Committee","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"2022010405180981400_b20","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2249.2007.03461.x","article-title":"Translational mini-review series on immunodeficiency: molecular defects in common variable immunodeficiency","volume":"149","author":"Bacchelli","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"2022010405180981400_b21","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1365-2249.2006.03138.x","article-title":"Patient-centred screening for primary immunodeficiency: a multi-stage diagnostic protocol designed for non-immunologists","volume":"145","author":"De Vries","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"2022010405180981400_b22","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2249.2006.03126.x","article-title":"Early indicators of immunodeficiency in adults and children: protocols for screening for primary immunological defects","volume":"145","author":"Sewell","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"2022010405180981400_b23","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1365-2249.2007.03432.x","article-title":"Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review","volume":"149","author":"Wood","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"2022010405180981400_b24","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jaci.2005.12.1347","article-title":"Primary immunodeficiency diseases: an update from the International Union of Immunological Societies primary immunodeficiency diseases classification committee meeting in Budapest 2005","volume":"117","author":"Notarangelo","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"2022010405180981400_b25","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jaci.2004.02.001","article-title":"Phagocyte immunodeficiencies and their infections","volume":"113","author":"Rosenzweig","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"2022010405180981400_b26","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1056\/NEJM200012073432307","article-title":"Immunodeficiency diseases caused by defects in phagocytes","volume":"343","author":"Lekstrom-Himes","year":"2000","journal-title":"N Engl J Med"},{"key":"2022010405180981400_b27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00062752-200701000-00007","article-title":"Genetics, biology and clinical management of myeloid cell primary immune deficiencies: chronic granulomatous disease and leukocyte adhesion deficiency","volume":"14","author":"Malech","year":"2007","journal-title":"Curr Opin Hematol"},{"key":"2022010405180981400_b28","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/BF01957525","article-title":"The management of chronic granulomatous disease","volume":"152","author":"Fischer","year":"1993","journal-title":"Eur J Pediatr"},{"key":"2022010405180981400_b29","first-page":"220","article-title":"Chronic granulomatous disease in adults","volume":"346","author":"Liese","year":"1995","journal-title":"Lancet"},{"key":"2022010405180981400_b30","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1056\/NEJMcps041234","article-title":"Unfashionably late","volume":"352","author":"Lukela","year":"2005","journal-title":"N Engl J Med"},{"key":"2022010405180981400_b31","volume-title":"\u2018Fatal granulomatous disease of childhood\u2019\u2003\u2212\u2003still fatal","author":"Abinun"},{"key":"2022010405180981400_b32","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0022-3476(05)82023-2","article-title":"Long-term itraconazoleprophylaxis against Aspergillus infections in thirty-two patients with chronic granulomatous disease","volume":"125","author":"Mouy","year":"1994","journal-title":"J Pediatr"},{"key":"2022010405180981400_b33","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa021931","article-title":"Itraconazole to prevent fungal infections in chronic granulomatous disease","volume":"348","author":"Gallin","year":"2003","journal-title":"N Engl J Med"},{"key":"2022010405180981400_b34","first-page":"113","article-title":"Treatment of chronic granulomatous disease","volume":"5","author":"Seger","year":"1994","journal-title":"Immunodeficiency"},{"key":"2022010405180981400_b35","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJM199102213240801","article-title":"A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease","volume":"324","author":"International Chronic Granulomatous Disease Cooperative Study Group","year":"1991","journal-title":"N Engl J Med"},{"key":"2022010405180981400_b36","first-page":"295","article-title":"Recombinant human interferon-gamma in patients with chronic granulomatous disease \u2013 European follow up study","volume":"154","author":"Weening","year":"1995","journal-title":"Eur J Pediatr"},{"key":"2022010405180981400_b37","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/01.inf.0000050460.55352.dd","article-title":"Caspofungin therapy for Aspergillus lung infection in a boy with chronic granulomatous disease","volume":"22","author":"Sallmann","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"2022010405180981400_b38","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/01.inf.0000130741.01940.ff","article-title":"Successful elimination of an invasive Aspergillus nidulans lung infection by voriconazole after failure of a combination of caspofungin and liposomal amphotericin B in a boy with chronic granulomatous disease","volume":"23","author":"R\u00f6sen-Wolff","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"2022010405180981400_b39","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1056\/NEJM200103223441203","article-title":"Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft","volume":"344","author":"Horwitz","year":"2001","journal-title":"N Engl J Med"},{"key":"2022010405180981400_b40","volume-title":"Moderate LAD-1 deficiency in a patient previously diagnosed with pyoderma gangrenosum","author":"Rodr\u00edguez-Gallego"},{"key":"2022010405180981400_b41","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0952-7915(98)80114-3","article-title":"Mendelian susceptibility to mycobacterial infection in man","volume":"10","author":"Altare","year":"1998","journal-title":"Curr Opin Immunol"},{"key":"2022010405180981400_b42","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0889-8561(05)70134-X","article-title":"Diagnosis and management of inheritable disorders of interferon-\u03b3-mediated immunity","volume":"20","author":"Picard","year":"2000","journal-title":"Immunol Allergy Clin North Am"},{"key":"2022010405180981400_b43","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1136\/jmg.2006.043406","article-title":"A novel X-linked recessive form of Mendelian susceptibility to mycobacterial disease","volume":"44","author":"Bustamante","year":"2007","journal-title":"J Med Genet"},{"key":"2022010405180981400_b44","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/120347540100500107","article-title":"A case of cutaneous Mycobacterium chelonae abscessus infection in a renal transplant patient","volume":"5","author":"Endzweig","year":"2001","journal-title":"J Cutan Med Surg"},{"key":"2022010405180981400_b45","first-page":"277","article-title":"Tuberculous gumma (cutaneous metastatic tuberculous abscess) with underlying lymphoma","volume":"66","author":"Kalaria","year":"2000","journal-title":"Cutis"},{"key":"2022010405180981400_b46","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJM199903043400904","article-title":"Hyper-IgE syndrome with recurrent infections\u2003\u2212\u2003an autosomal dominant multisystem disorder","volume":"340","author":"Grimbacher","year":"1999","journal-title":"N Engl J Med"},{"key":"2022010405180981400_b47","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jaad.2005.10.022","article-title":"Hyperimmunoglobulin E syndrome: two cases and a review of the literature","volume":"54","author":"DeWitt","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"2022010405180981400_b48","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa073687","article-title":"STAT3 mutations in the Hyper-IgE syndrome","volume":"357","author":"Holland","year":"2007","journal-title":"N Engl J Med"},{"key":"2022010405180981400_b49","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1034\/j.1600-065X.2000.17803.x","article-title":"The Wiskott\u2013Aldrich syndrome: disordered actin dynamics in haematopoietic cells","volume":"178","author":"Thrasher","year":"2000","journal-title":"Immunol Rev"},{"key":"2022010405180981400_b50","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jaci.2006.02.005","article-title":"The Wiskott\u2013Aldrich syndrome","volume":"117","author":"Ochs","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"2022010405180981400_b51","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1182\/blood.V97.6.1598","article-title":"Impact of donor type on outcome of bone marrow transplantation for Wiskott\u2013Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program","volume":"97","author":"Filipovich","year":"2001","journal-title":"Blood"},{"key":"2022010405180981400_b52","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1046\/j.1365-4362.2003.01891.x","article-title":"Sweet's syndrome revisited: a review of disease concepts","volume":"42","author":"Cohen","year":"2003","journal-title":"Int J Dermatol"},{"key":"2022010405180981400_b53","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1172-2-19","article-title":"Pyoderma gangrenosum\u2003\u2212\u2003a review","volume":"2","author":"Wollina","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"2022010405180981400_b54","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.intimp.2005.11.017","article-title":"Use of IGIV in the treatment of atopic dermatitis, urticaria, scleromyxedema, pyoderma gangrenosum, psoriasis and pretibial myxedema","volume":"6","author":"Jolles","year":"2006","journal-title":"Int Immunopharmacol"},{"key":"2022010405180981400_b55","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/gut.2005.074815","article-title":"Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo-controlled trial","volume":"55","author":"Brooklyn","year":"2006","journal-title":"Gut"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2008.03640.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2008.03640.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/152\/3\/397\/42045378\/j.1365-2249.2008.03640.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/152\/3\/397\/42045378\/j.1365-2249.2008.03640.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T05:26:44Z","timestamp":1641274004000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/152\/3\/397\/6457573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,16]]},"references-count":55,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2008,4,16]]},"published-print":{"date-parts":[[2008,5,6]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2008.03640.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2008,6]]},"published":{"date-parts":[[2008,4,16]]}}}